RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引：77
|
作者：
CAVALLI, F
GOLDHIRSCH, A
JUNGI, F
MARTZ, G
MERMILLOD, B
ALBERTO, P
机构：
[1] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND
[2] INSELSPITAL,LUDWIG INST CANC RES,CH-3010 BERN,SWITZERLAND
[3] KANTONSSPITAL,MED KLIN C,DIV ONCOL,CH-9006 ST GALLEN,SWITZERLAND
[4] UNIV HOSP ZURICH,DIV ONCOL,CH-8091 ZURICH,SWITZERLAND
[5] HOP CANTONAL,SWISS GRP CLIN CANC RES,STAT OFF,CH-1211 GENEVA 4,SWITZERLAND
[6] HOP CANTONAL,DIV ONCOL,CH-1211 GENEVA 4,SWITZERLAND
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 05期
关键词：
D O I：
10.1200/JCO.1984.2.5.414
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 419
页数：6
相关论文
共 50 条
  • [1] HIGH-DOSE VERSUS LOW-DOSE MEDROXYPROGESTERONE ACETATE - A RANDOMIZED TRIAL IN ADVANCED BREAST-CANCER
    GALLAGHER, CJ
    CAIRNDUFF, F
    SMITH, IE
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (12): : 1895 - 1900
  • [2] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
    GALLAGHER, CJ
    MCKINNA, JA
    CAIRNDUFF, F
    SMITH, IE
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
  • [3] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS TAMOXIFEN - A RANDOMIZED CROSSOVER TRIAL IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    VANVEELEN, H
    WILLEMSE, PHB
    TJABBES, T
    SCHWEITZER, MJH
    SLEIJFER, DT
    CANCER, 1986, 58 (01) : 7 - 13
  • [4] WEEKLY LOW-DOSE DOXORUBICIN WITH OR WITHOUT HIGH-DOSE MEDROXYPROGESTERONE ACETATE AS SECONDARY-TREATMENT IN METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL
    ELOMAA, I
    BLOMQVIST, C
    RISSANEN, P
    MANTYLA, M
    ACTA ONCOLOGICA, 1988, 27 (03) : 297 - 299
  • [5] RANDOMIZED TRIAL OF LOW VS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF POST-MENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    CAVALLI, F
    GOLDHIRSCH, A
    JUNGI, G
    MARTZ, G
    MERMILLOD, B
    SCHAFER, P
    ALBERTO, P
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1983, 19 (03): : R11 - R11
  • [6] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED MALE BREAST-CANCER
    PANNUTI, F
    MARTONI, A
    BUSUTTI, L
    GRAMELLINI, M
    PIANA, E
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1763 - 1765
  • [7] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    HEDLEY, D
    DALGLEISH, A
    COATES, A
    FOX, R
    RAGHAVAN, D
    TATTERSALL, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 205 - 205
  • [8] HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) TREATMENT IN ADVANCED BREAST-CANCER - REVIEW
    GANZINA, F
    TUMORI JOURNAL, 1979, 65 (05): : 563 - 585
  • [9] A PHASE-III TRIAL OF ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) VERSUS MEPITIOSTANE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER
    IZUO, M
    YOSHIDA, M
    TOMINAGA, T
    ABE, O
    ENOMOTO, K
    NOMURA, Y
    KUBO, K
    TAKATANI, O
    CANCER, 1985, 56 (11) : 2576 - 2579
  • [10] HIGH-DOSE VERSUS LOW-DOSE CMFP REGIMEN IN ADVANCED BREAST-CANCER
    KUMAR, A
    KHANNA, NN
    PANT, GC
    KHANNA, S
    JOURNAL OF SURGICAL ONCOLOGY, 1984, 25 (04) : 300 - 302
12345